首页 | 本学科首页   官方微博 | 高级检索  
     

再切除在肝癌复发治疗中的作用和地位
引用本文:武金才,陆才德,彭淑牖,戴德坚. 再切除在肝癌复发治疗中的作用和地位[J]. 中华肝胆外科杂志, 2004, 10(1): 14-16
作者姓名:武金才  陆才德  彭淑牖  戴德坚
作者单位:1. 324000,浙江省,衢州市人民医院肝胆外科
2. 浙江大学医学院附属二院
摘    要:目的 探讨再切除在肝癌术后复发治疗中的价值。方法 回顾性分析1988~1999年30例肝癌复发再手术切除的随访资料。结果 对30例肝癌术后复发病人共行33例次手术,首次手术后1,2,3,5年总生存率分别为93.3,73.3,56.7,36.7%。第一次再手术后1,3,5年生存率分别为63.3,23.3,13.3%。肺转移切除后1,3,5年生存率分别为71.4,42.9,28.6%。结论 肝癌术后复发行再切除能显著提高病人远期生存率,是目前肝癌术后复发的首选治疗方案。

关 键 词:肝癌 再切除 术后复发 生存率 癌复发 治疗中 病人 远期
修稿时间:2002-09-09

Role of re-resection in treatment of recurrent hepatocellular carcinoma
WU Jincai ,LU Caide,PENG Shuyou,et al.. Role of re-resection in treatment of recurrent hepatocellular carcinoma[J]. Chinese Journal of Hepatobiliary Surgery, 2004, 10(1): 14-16
Authors:WU Jincai   LU Caide  PENG Shuyou  et al.
Affiliation:WU Jincai *,LU Caide,PENG Shuyou,et al. * Department of Hepatobilairy Surgery,the People's Hospital of Quzhou City,Quzhou 324000,P. R. China
Abstract:Objective To investigate the role of re-resection in treatment of recurrent hepatocellular carcinoma (HCC). Methods The follow-up data of 30 cases of recurrent HCC receiving re-resection in our hospital from 1988 to 1999 were retrospectively analyzed. Results The repeated resection was performed for 33 times in 30 cases of recurrent HCC. The 1-, 2-, 3- and 5-year survival rates in the patients after the first operation were 93.3%, 73.3%, 56.7% and 36.7%, respectively. The 1-, 3- and 5-year survival rates were 63.3%, 23.3% and 13.3%, respectively, after the first re-resection and 71.4%, 42.9% and 28.6%, respectively, after resection of pulmonary metastatic lesions. Conclusions Re-resection of recurrent HCC can markedly prolong the survival of patients. Thus it is of first choice for treatment of recurrent HCC after the first operation.
Keywords:Liver neoplasm  Re-operation  Recurrence
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号